Advertisement
Canada markets open in 2 hours 10 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7315
    +0.0017 (+0.23%)
     

  • CRUDE OIL

    82.92
    +0.11 (+0.13%)
     

  • Bitcoin CAD

    87,116.27
    -3,695.11 (-4.07%)
     

  • CMC Crypto 200

    1,349.75
    -32.82 (-2.37%)
     

  • GOLD FUTURES

    2,341.10
    +2.70 (+0.12%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,474.00
    -190.50 (-1.08%)
     

  • VOLATILITY

    16.26
    +0.29 (+1.81%)
     

  • FTSE

    8,088.60
    +48.22 (+0.60%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6817
    -0.0002 (-0.03%)
     

Raptor Pharmaceuticals (RPTP) Jumps: Stock Adds 28.2% in Session

Zacks Equity Research

Raptor Pharmaceuticals Corp. (RPTP) was a big mover last session, as its shares rose over 28% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $8.09 to $10.49 in the past one-month timeframe.

In the last 30 days, the company did not witness any estimate revisions and the Zacks Consensus Estimate also remained unchanged. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Raptor Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Other better-ranked stocks in the med-drugs industry include Actelion Ltd. (ALIOF), Cambrex Corporation. (CBM) and Curis, Inc. (CRIS). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



RAPTOR PHARMACEUTICAL CORP (RPTP): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report

CURIS INC (CRIS): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report


Zacks Investment Research